retatrutide type 2 diabetes trial results 2024 Summary of the highest percent weight change in completed phase and 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

To our knowledge, notwithstanding the fact that several antidiabetic medications are commonly used off-label for RH, this is the first published case series describing the efficacy of metformin in RH

Finally, the increasing off-label use of GLP-1 RAs for weight loss in non-diabetic individuals may further exacerbate access limitations and drug shortages, potentially disadvantaging patients with T2DM

The phase 2 trial showed 22.8% average weight loss at 48 weeks with the 8mg dose, only 1.4 percentage points less than the 12mg dose

This risk increased if someone took Ozempic for more than 1.5 years

We have found that psychological and emotional support is also important